These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32418496)

  • 1. Gut Pathology and Its Rescue by ACE2 (Angiotensin-Converting Enzyme 2) in Hypoxia-Induced Pulmonary Hypertension.
    Sharma RK; Oliveira AC; Yang T; Karas MM; Li J; Lobaton GO; Aquino VP; Robles-Vera I; de Kloet AD; Krause EG; Bryant AJ; Verma A; Li Q; Richards EM; Raizada MK
    Hypertension; 2020 Jul; 76(1):206-216. PubMed ID: 32418496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE2 overexpression in corticotropin-releasing-hormone cells offers protection against pulmonary hypertension.
    Oliveira AC; Karas MM; Alves M; He J; de Kloet AD; Krause EG; Richards EM; Bryant AJ; Raizada MK
    Front Neurosci; 2023; 17():1223733. PubMed ID: 37638323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglial Cells Impact Gut Microbiota and Gut Pathology in Angiotensin II-Induced Hypertension.
    Sharma RK; Yang T; Oliveira AC; Lobaton GO; Aquino V; Kim S; Richards EM; Pepine CJ; Sumners C; Raizada MK
    Circ Res; 2019 Mar; 124(5):727-736. PubMed ID: 30612527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of pulmonary hypertension by Angiotensin-converting enzyme 2 gene transfer.
    Yamazato Y; Ferreira AJ; Hong KH; Sriramula S; Francis J; Yamazato M; Yuan L; Bradford CN; Shenoy V; Oh SP; Katovich MJ; Raizada MK
    Hypertension; 2009 Aug; 54(2):365-71. PubMed ID: 19564552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension.
    Shenoy V; Ferreira AJ; Qi Y; Fraga-Silva RA; Díez-Freire C; Dooies A; Jun JY; Sriramula S; Mariappan N; Pourang D; Venugopal CS; Francis J; Reudelhuber T; Santos RA; Patel JM; Raizada MK; Katovich MJ
    Am J Respir Crit Care Med; 2010 Oct; 182(8):1065-72. PubMed ID: 20581171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive effects of exercise involve reshaping of gut microbiota and improvement of gut-brain axis in spontaneously hypertensive rat.
    Xia WJ; Xu ML; Yu XJ; Du MM; Li XH; Yang T; Li L; Li Y; Kang KB; Su Q; Xu JX; Shi XL; Wang XM; Li HB; Kang YM
    Gut Microbes; 2021; 13(1):1-24. PubMed ID: 33382364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The developing gut-lung axis: postnatal growth restriction, intestinal dysbiosis, and pulmonary hypertension in a rodent model.
    Wedgwood S; Warford C; Agvatisiri SR; Thai PN; Chiamvimonvat N; Kalanetra KM; Lakshminrusimha S; Steinhorn RH; Mills DA; Underwood MA
    Pediatr Res; 2020 Feb; 87(3):472-479. PubMed ID: 31537010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary arterial hypertension-associated changes in gut pathology and microbiota.
    Sharma RK; Oliveira AC; Yang T; Kim S; Zubcevic J; Aquino V; Lobaton GO; Goel R; Richards EM; Raizada MK
    ERJ Open Res; 2020 Jul; 6(3):. PubMed ID: 32743008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal matter transplant from Ace2 overexpressing mice counteracts chronic hypoxia-induced pulmonary hypertension.
    Oliveira AC; Yang T; Li J; Sharma RK; Karas MK; Bryant AJ; de Kloet AD; Krause EG; Joe B; Richards EM; Raizada MK
    Pulm Circ; 2022 Jan; 12(1):e12015. PubMed ID: 35506083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats.
    Li G; Liu Y; Zhu Y; Liu A; Xu Y; Li X; Li Z; Su J; Sun L
    Lung; 2013 Aug; 191(4):327-36. PubMed ID: 23652350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAP kinase kinase kinase-2 (MEKK2) regulates hypertrophic remodeling of the right ventricle in hypoxia-induced pulmonary hypertension.
    Brown RD; Ambler SK; Li M; Sullivan TM; Henry LN; Crossno JT; Long CS; Garrington TP; Stenmark KR
    Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H269-81. PubMed ID: 23125215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrapulmonary activation of the angiotensin-converting enzyme type 2/angiotensin 1-7/G-protein-coupled Mas receptor axis attenuates pulmonary hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.
    Hampl V; Herget J; Bíbová J; Baňasová A; Husková Z; Vaňourková Z; Jíchová Š; Kujal P; Vernerová Z; Sadowski J; Červenka L
    Physiol Res; 2015; 64(1):25-38. PubMed ID: 25194138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE2 (Angiotensin-Converting Enzyme 2)-Mediated Protection From Pulmonary Hypertension: Lung-Gut Axis at Center Stage.
    Gheblawi M; Wang K; Oudit GY
    Hypertension; 2020 Jul; 76(1):28-29. PubMed ID: 32520621
    [No Abstract]   [Full Text] [Related]  

  • 14. Overexpression of ACE2 prevents hypoxia-induced pulmonary hypertension in rats by inhibiting proliferation and immigration of PASMCs.
    Hu HH; Zhang RF; Dong LL; Chen EG; Ying KJ
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3968-3980. PubMed ID: 32329874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension.
    Ferreira AJ; Shenoy V; Yamazato Y; Sriramula S; Francis J; Yuan L; Castellano RK; Ostrov DA; Oh SP; Katovich MJ; Raizada MK
    Am J Respir Crit Care Med; 2009 Jun; 179(11):1048-54. PubMed ID: 19246717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nuclear factor erythroid 2-related factor 2 activator oltipraz attenuates chronic hypoxia-induced cardiopulmonary alterations in mice.
    Eba S; Hoshikawa Y; Moriguchi T; Mitsuishi Y; Satoh H; Ishida K; Watanabe T; Shimizu T; Shimokawa H; Okada Y; Yamamoto M; Kondo T
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):324-33. PubMed ID: 23590302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMP-activated Protein Kinase Phosphorylation of Angiotensin-Converting Enzyme 2 in Endothelium Mitigates Pulmonary Hypertension.
    Zhang J; Dong J; Martin M; He M; Gongol B; Marin TL; Chen L; Shi X; Yin Y; Shang F; Wu Y; Huang HY; Zhang J; Zhang Y; Kang J; Moya EA; Huang HD; Powell FL; Chen Z; Thistlethwaite PA; Yuan ZY; Shyy JY
    Am J Respir Crit Care Med; 2018 Aug; 198(4):509-520. PubMed ID: 29570986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral delivery of Angiotensin-converting enzyme 2 and Angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension.
    Shenoy V; Kwon KC; Rathinasabapathy A; Lin S; Jin G; Song C; Shil P; Nair A; Qi Y; Li Q; Francis J; Katovich MJ; Daniell H; Raizada MK
    Hypertension; 2014 Dec; 64(6):1248-59. PubMed ID: 25225206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The beneficial effects of angiotensin-converting enzyme II (ACE2) activator in pulmonary hypertension secondary to left ventricular dysfunction.
    Chen IC; Lin JY; Liu YC; Chai CY; Yeh JL; Hsu JH; Wu BN; Dai ZK
    Int J Med Sci; 2020; 17(16):2594-2602. PubMed ID: 33029102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tsantan Sumtang attenuated chronic hypoxia-induced right ventricular structure remodeling and fibrosis by equilibrating local ACE-AngII-AT1R/ACE2-Ang1-7-Mas axis in rat.
    Dang Z; Su S; Jin G; Nan X; Ma L; Li Z; Lu D; Ge R
    J Ethnopharmacol; 2020 Mar; 250():112470. PubMed ID: 31862407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.